|
⚲
|
| Keyboard |
| Gault Cheryl
✚
|
|
|---|---|
| CIK # | 0001839046 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001839046] | |
| 4 | [0001839046] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Rapport Therapeutics Inc | |
| Gault Cheryl | |
| Cyclerion Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2026-03-30 | Sell | 2,839 | $28.55 | 81,053 |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2026-03-30 | Sell | 7,161 | $28.04 | 200,794 |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2026-03-05 | Sell | 2,014 | $28.93 | 58,265 |
|
Rapport Therapeutics Inc RAPP
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 132,000 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2025-11-26 | Sell | 5,000 | $30.10 | 150,500 |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2025-11-26 | Option exercise | 5,000 | $1.80 | 9,000 |
|
Rapport Therapeutics Inc RAPP
Stock Option (Right to Buy) · derivative
|
2025-11-26 | Option exercise | 5,000 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2025-03-03 | Grant | 13,987 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Stock Option (Right to Buy) · derivative
|
2025-02-03 | Grant | 129,000 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Stock Option (Right to Buy) · derivative
|
2024-06-06 | Grant | 88,442 | $0.00 | |
|
Cyclerion Therapeutics Inc CYCN
Employee Stock Option (Right to Buy) · derivative
|
2022-01-20 | Grant | 135,000 | $0.00 | |
|
Cyclerion Therapeutics Inc CYCN
Employee Stock Option (Right to Buy) · derivative
|
2021-12-09 | Grant | 100,000 | $0.00 |